These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
328 related items for PubMed ID: 34819392
1. CD8+ T Cells Expressing an HLA-DR1 Chimeric Antigen Receptor Target Autoimmune CD4+ T Cells in an Antigen-Specific Manner and Inhibit the Development of Autoimmune Arthritis. Whittington KB, Prislovsky A, Beaty J, Albritton L, Radic M, Rosloniec EF. J Immunol; 2022 Jan 01; 208(1):16-26. PubMed ID: 34819392 [Abstract] [Full Text] [Related]
2. Engineered regulatory T cells coexpressing MHC class II:peptide complexes are efficient inhibitors of autoimmune T cell function and prevent the development of autoimmune arthritis. Qian Z, Latham KA, Whittington KB, Miller DC, Brand DD, Rosloniec EF. J Immunol; 2013 Jun 01; 190(11):5382-91. PubMed ID: 23630354 [Abstract] [Full Text] [Related]
3. Collagen-induced arthritis mediated by HLA-DR1 (*0101) and HLA-DR4 (*0401). Rosloniec EF, Whittington KB, He X, Stuart JM, Kang AH. Am J Med Sci; 2004 Apr 01; 327(4):169-79. PubMed ID: 15084912 [Abstract] [Full Text] [Related]
4. The impact of glycosylation on HLA-DR1-restricted T cell recognition of type II collagen in a mouse model. von Delwig A, Altmann DM, Isaacs JD, Harding CV, Holmdahl R, McKie N, Robinson JH. Arthritis Rheum; 2006 Feb 01; 54(2):482-91. PubMed ID: 16447222 [Abstract] [Full Text] [Related]
5. Characterization of T cell phenotype and function in a double transgenic (collagen-specific TCR/HLA-DR1) humanized model of arthritis. Tang B, Kim S, Hammond S, Cullins DL, Brand DD, Rosloniec EF, Stuart JM, Postlethwaite AE, Kang AH, Myers LK. Arthritis Res Ther; 2014 Jan 10; 16(1):R7. PubMed ID: 24405551 [Abstract] [Full Text] [Related]
6. Inhibition of macropinocytosis blocks antigen presentation of type II collagen in vitro and in vivo in HLA-DR1 transgenic mice. von Delwig A, Hilkens CM, Altmann DM, Holmdahl R, Isaacs JD, Harding CV, Robertson H, McKie N, Robinson JH. Arthritis Res Ther; 2006 Jan 10; 8(4):R93. PubMed ID: 16704744 [Abstract] [Full Text] [Related]
9. An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen. Rosloniec EF, Brand DD, Myers LK, Whittington KB, Gumanovskaya M, Zaller DM, Woods A, Altmann DM, Stuart JM, Kang AH. J Exp Med; 1997 Mar 17; 185(6):1113-22. PubMed ID: 9091584 [Abstract] [Full Text] [Related]
15. Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen. Rosloniec EF, Brand DD, Myers LK, Esaki Y, Whittington KB, Zaller DM, Woods A, Stuart JM, Kang AH. J Immunol; 1998 Mar 15; 160(6):2573-8. PubMed ID: 9510154 [Abstract] [Full Text] [Related]
19. T cell receptors recognizing type II collagen in HLA-DR-transgenic mice characterized by highly restricted V beta usage. He X, Rosloniec EF, Myers LK, McColgan WL, Gumanovskaya M, Kang AH, Stuart JM. Arthritis Rheum; 2004 Jun 15; 50(6):1996-2004. PubMed ID: 15188377 [Abstract] [Full Text] [Related]
20. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8. Berg L, Rönnelid J, Sanjeevi CB, Lampa J, Klareskog L. Arthritis Res; 2000 Jun 15; 2(1):75-84. PubMed ID: 11219392 [Abstract] [Full Text] [Related] Page: [Next] [New Search]